Does tirzepatide treatment improve skeletal muscle composition?
- PMID: 40318684
- DOI: 10.1016/S2213-8587(25)00054-3
Does tirzepatide treatment improve skeletal muscle composition?
Conflict of interest statement
I have received fees for consultancy and scientific talks from Allergan, AstraZeneca, Boehringer Ingelheim, Gilead, Genkyotex, GSK, Intercept Pharma, Lilly, Merck Sharpe & Dohme, Novartis, Novo Nordisk, Pfizer, and Sanofi; support for attending meetings or travel from AstraZeneca, Boehringer Ingelheim, GSK, Lilly, Pfizer, and Sanofi; and research support from AstraZeneca, Boehringer Ingelheim, Sanofi, DSM Nutritional Products, and Roche Diagnostics. This work was aided in part by funding from the European Innovative Health Initiative SOPHIA and the German Federal Ministry of Education and Research to the German Center of Diabetes Research.
Comment on
-
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial.Lancet Diabetes Endocrinol. 2025 Jun;13(6):482-493. doi: 10.1016/S2213-8587(25)00027-0. Epub 2025 Apr 30. Lancet Diabetes Endocrinol. 2025. PMID: 40318682 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
